Noradrenergic Activity, Cognition and Major Depressive Disorder

• Status: Completed
• Trial end date: 2018-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study investigates influences of nordadrenergic activity on cognition in patients with major depression regarding influences of early life stress.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Treatments: Yohimbine

Criteria

Inclusion Criteria:

• diagnosis of major depression

• experience of early life trauma

Exclusion Criteria:

• severe illness

• Alzheimer´s

• schizophrenia

• bipolar disorder

• control group: - diagnosis of major depression/ experience of early life trauma